Skye Bioscience, Inc. Common Stock (SKYE) — Cash Flow Reinvestment Rate
Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Reinvestment Rate of 8.56x as of June 2014, reinvesting $67.83K (capex $67.83K ) from operating cash flow of $7.92K. Check earnings quality score of Skye Bioscience, Inc. Common Stock to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Skye Bioscience, Inc. Common Stock Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for Skye Bioscience, Inc. Common Stock across 1 annual periods. Explore SKYE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Skye Bioscience, Inc. Common Stock (2012–2012)
Year-by-year capital reinvestment analysis for Skye Bioscience, Inc. Common Stock. For live market cap and broader valuation context, see SKYE market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | $0.00 | $1.93K | $0.00 | — |